Creating a new sensor platform for faster drug discovery
Development of a chemical reaction sensor array platform for label-free, real-time kinetic analysis of enzyme-substrate reactions to enable high-throughput drug discovery
This study is working on a new sensor that can quickly and accurately track how enzymes interact with substances, which could help find new drugs faster, potentially leading to better treatments for conditions like Alzheimer's disease.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Spoc Proteomics INC. NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project ID | NIH-10677748 on NIH RePORTER |
What this research studies
This research focuses on developing a novel sensor platform that allows for real-time monitoring of enzyme-substrate reactions, which is crucial for identifying new drug candidates. By utilizing advanced biosensor technology, the project aims to enhance the efficiency of high-throughput screening (HTS) methods, making them more accurate and faster. Patients may benefit from this research as it could lead to quicker development of effective new treatments for various conditions, including Alzheimer's disease. The approach involves using a specialized sensor that detects molecular interactions with high sensitivity and scalability.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that currently lack effective treatments, such as Alzheimer's disease.
Not a fit: Patients with conditions that are already well-managed by existing therapies may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly accelerate the development of new and effective drug treatments for patients.
How similar studies have performed: Other research has shown promise in using advanced biosensor technologies for drug discovery, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Scottsdale, United States
- Spoc Proteomics INC. — Scottsdale, United States (Active)
Researchers
- Principal investigator: Takulapalli, Bharath — Spoc Proteomics INC.
- Study coordinator: Takulapalli, Bharath
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.